# A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)

> **NCT01174355** · PHASE1,PHASE2 · COMPLETED · sponsor: **NeuroDerm Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Attention Deficit and Hyperactivity Disorder

## Interventions

- **DRUG:** ND0801

## Key facts

- **NCT ID:** NCT01174355
- **Lead sponsor:** NeuroDerm Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01174355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01174355, "A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01174355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*